New Test for HER2 Breast Cancer to Personalize Therapy

The multiparameter molecular classifier test has a high negative predictive value (NPV), underscoring its accuracy for identifying patients who may not be good candidates for treatment de-escalation.
Medscape Medical News

source https://www.medscape.com/viewarticle/993904?src=rss